| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |

From the Department of Pathology and Skin Cancer Research
Laboratories,*
Cardinal Bernardin Cancer Center, Loyola
University Medical Center, Maywood, Illinois; and the Department of
Microbiology, Molecular Genetics and
Immunology,
University of Kansas Medical
Center, Kansas City, Kansas
Human herpesvirus 8 (HHV-8) is a
2-herpesvirus consistently
identified in Kaposis sarcoma (KS), primary effusion
lymphoma, and multicentric Castlemans disease. Although HHV-8
infection appears to be necessary, it may not be sufficient for
development of KS without the involvement of other cofactors. One
potentially important cofactor is HIV-1. HIV-1-infected cells produce
HIV-1-related proteins and cytokines, both of which have been
shown to promote growth of KS cells in vitro. Though
HIV-1 is not absolutely necessary for KS development, KS is the
most frequent neoplasm in AIDS patients, and AIDS-KS is
recognized as a particularly aggressive form of the disease. To
determine whether HIV-1 could participate in the pathogenesis of KS by
modulating HHV-8 replication (rather than by inducing
immunodeficiency), HIV-1-infected T cells were cocultured with
the HHV-8-infected cell line, BCBL-1. The results demonstrate
soluble factors produced by or in response to HIV-1-infected T cells
induced HHV-8 replication, as determined by production of lytic
phase mRNA transcripts, viral proteins, and detection
of progeny virions. By focusing on cytokines produced in the coculture
system, several cytokines known to be important in growth and
proliferation of KS cells in vitro, particularly
Oncostatin M, hepatocyte growth factor/scatter factor,
and interferon-
, were found to induce HHV-8 lytic
replication when added individually to BCBL-1 cells. These results
suggest specific cytokines can play an important role in the initiation
and progression of KS through reactivation of HHV-8. Thus,
HIV-1 may participate more directly than previously recognized in KS by
promoting HHV-8 replication and, hence, increasing
local HHV-8 viral load.
This article has been cited by other articles:
![]() |
Y. Zeng, X. Zhang, Z. Huang, L. Cheng, S. Yao, D. Qin, X. Chen, Q. Tang, Z. Lv, L. Zhang, et al. Intracellular Tat of Human Immunodeficiency Virus Type 1 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus: Role of JAK/STAT Signaling J. Virol., March 1, 2007; 81(5): 2401 - 2417. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Carroll, H. L. Kenerson, R. S. Yeung, and M. Lagunoff Latent Kaposi's Sarcoma-Associated Herpesvirus Infection of Endothelial Cells Activates Hypoxia-Induced Factors J. Virol., November 1, 2006; 80(21): 10802 - 10812. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Miller, J. R. Berger, Y. Mootoor, S. A. Avdiushko, H. Zhu, and R. J. Kryscio High prevalence of multiple human herpesviruses in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. J. Clin. Microbiol., July 1, 2006; 44(7): 2409 - 2415. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cohen, C. Brodie, and R. Sarid An essential role of ERK signalling in TPA-induced reactivation of Kaposi's sarcoma-associated herpesvirus. J. Gen. Virol., April 1, 2006; 87(Pt 4): 795 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Chang, H. J. Brown, A. Collado-Hidalgo, J. M. Arevalo, Z. Galic, T. L. Symensma, L. Tanaka, H. Deng, J. A. Zack, R. Sun, et al. {beta}-Adrenoreceptors Reactivate Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication via PKA-Dependent Control of Viral RTA J. Virol., November 1, 2005; 79(21): 13538 - 13547. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lu, Y. Zeng, Z. Huang, L. Huang, C. Qian, G. Tang, and D. Qin Human Herpesvirus 6 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus Am. J. Pathol., January 1, 2005; 166(1): 173 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. P. Pozharskaya, L. L. Weakland, and M. K. Offermann Inhibition of infectious human herpesvirus 8 production by gamma interferon and alpha interferon in BCBL-1 cells J. Gen. Virol., October 1, 2004; 85(10): 2779 - 2787. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gandhi, D.M. Koelle, N. Ameli, P. Bacchetti, J.S. Greenspan, M. Navazesh, K. Anastos, and R.M. Greenblatt Prevalence of Human Herpesvirus-8 Salivary Shedding in HIV Increases with CD4 Count J. Dent. Res., August 1, 2004; 83(8): 639 - 643. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Staudt, Y. Kanan, J. H. Jeong, J. F. Papin, R. Hines-Boykin, and D. P. Dittmer The Tumor Microenvironment Controls Primary Effusion Lymphoma Growth in Vivo Cancer Res., July 15, 2004; 64(14): 4790 - 4799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Milligan, M. Robinson, E. O'Donnell, and D. J. Blackbourn Inflammatory Cytokines Inhibit Kaposi's Sarcoma-Associated Herpesvirus Lytic Gene Transcription in In Vitro-Infected Endothelial Cells J. Virol., March 1, 2004; 78(5): 2591 - 2596. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Inoue, J. Winter, R. B. Lal, M. K. Offermann, and S. Koyano Characterization of Entry Mechanisms of Human Herpesvirus 8 by Using an Rta-Dependent Reporter Cell Line J. Virol., July 15, 2003; 77(14): 8147 - 8152. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Dourmishev, A. L. Dourmishev, D. Palmeri, R. A. Schwartz, and D. M. Lukac Molecular Genetics of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Epidemiology and Pathogenesis Microbiol. Mol. Biol. Rev., June 1, 2003; 67(2): 175 - 212. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Pati, J. S. Foulke Jr., O. Barabitskaya, J. Kim, B. C. Nair, D. Hone, J. Smart, R. A. Feldman, and M. Reitz Human Herpesvirus 8-Encoded vGPCR Activates Nuclear Factor of Activated T Cells and Collaborates with Human Immunodeficiency Virus Type 1 Tat J. Virol., May 15, 2003; 77(10): 5759 - 5773. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tang, G. M. Gordon, M. G. Muller, M. Dahiya, and K. E. Foreman Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Induces Expression of the Helix-Loop-Helix Protein Id-1 in Human Endothelial Cells J. Virol., May 15, 2003; 77(10): 5975 - 5984. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Malnati, F. Broccolo, S. Nozza, L. Sarmati, S. Ghezzi, G. Locatelli, F. Delfanti, B. Capiluppi, A. Careddu, M. Andreoni, et al. Retrospective analysis of HHV-8 viremia and cellular viral load in HIV-seropositive patients receiving interleukin 2 in combination with antiretroviral therapy Blood, August 13, 2002; 100(5): 1575 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sakakibara, K. Ueda, J. Chen, T. Okuno, and K. Yamanishi Octamer-Binding Sequence Is a Key Element for the Autoregulation of Kaposi's Sarcoma-Associated Herpesvirus ORF50/Lyta Gene Expression J. Virol., August 1, 2001; 75(15): 6894 - 6900. [Abstract] [Full Text] |
||||
![]() |
J. P. Zoeteweij, A. V. Moses, A. S. Rinderknecht, D. A. Davis, W. W. Overwijk, R. Yarchoan, J. M. Orenstein, and A. Blauvelt Targeted inhibition of calcineurin signaling blocks calcium-dependent reactivation of Kaposi sarcoma-associated herpesvirus Blood, April 15, 2001; 97(8): 2374 - 2380. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-M. Huang, M.-F. Chao, M.-Y. Chen, H.-m. Shih, Y.-P. Chiang, C.-Y. Chuang, and C.-Y. Lee Reciprocal Regulatory Interaction between Human Herpesvirus 8 and Human Immunodeficiency Virus Type 1 J. Biol. Chem., April 13, 2001; 276(16): 13427 - 13432. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |